Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (101)

2024

  1. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis

    Kidney International, Vol. 105, Núm. 1, pp. 177-188

  2. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

2023

  1. Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy

    Pharmaceutics, Vol. 15, Núm. 1

  2. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

  3. Mechanical stress confers nuclear and functional changes in derived leukemia cells from persistent confined migration

    Cellular and Molecular Life Sciences, Vol. 80, Núm. 11

  4. Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

    American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158

  5. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  6. The Factor H protein family: The switchers of the complement alternative pathway

    Immunological Reviews, Vol. 313, Núm. 1, pp. 25-45

  7. Thrombotic microangiopathy in patients with malignant hypertension

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226

2022

  1. ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137

  3. Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain

    European Journal of Health Economics, Vol. 23, Núm. 3, pp. 551-558

  4. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  5. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153

  6. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

  7. Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

    Cancer immunology research, Vol. 10, Núm. 4, pp. 498-511

  8. Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies

    OncoImmunology, Vol. 11, Núm. 1

  9. Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

    Oncoimmunology, Vol. 11, Núm. 1, pp. 2034355

2021

  1. A Family Affair: Addressing the Challenges of Factor H and the Related Proteins

    Frontiers in Immunology, Vol. 12

  2. Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status

    Liver International, Vol. 41, Núm. 11, pp. 2646-2658